Auriga Presents New Investor Video Highlighting Drug Development Pipeline And Major Brand Expansions; CEO Details Strategic Initiatives To Create Both Short-Term Cash Flow And Long-Term Value In Pharmaceutical Marketplace

NORCROSS, Ga.--(BUSINESS WIRE)--Sept. 12, 2006--Auriga Laboratories, Inc. (OTCBB:ARGA), a specialty pharmaceutical company driving high-growth revenues through acquisition of valuable brand portfolios and innovative drug development programs, has presented a new investor information video outlining the Company's current product developments and successful acquisitions.